BioNTech aims to develop mRNA-based malaria vaccineA German company, Biontech, is currently developing a vaccine for malaria based on COVID-19 vaccine technology.A doctor tests a child for malaria at the Ithani-Asheri Hospital in Arusha, Tanzania(photo credit: REUTERS)
